As per MarkNtel Advisors The Global Amyotrophic Lateral Sclerosis Treatment Market size was valued at around USD 0.72 billion in 2024 and is projected to reach USD 0.97 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.1% during the forecast period, i.e., 2025-30.

 Amyotrophic Lateral Sclerosis Treatment Market Systems Market Analysis:

The market is expanding as a result of more funding and investments made by different organizations. Amyotrophic Lateral Sclerosis is becoming more prevalent worldwide which is driving the market toward new prospects. Additionally, pipeline medications and treatments along with technological developments in diagnostics are attempting to meet the market’s increasing demand. Moreover, ALS researchers, hospitals, and manufacturers are receiving subsidies and investments from government programs and other regulatory factors which will ultimately accelerate market growth.Since, there is currently no cure for ALS, the need for new and improved therapies is increasing drastically..

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Explore the Insights – Download a Free Sample:  https://www.marknteladvisors.com/query/request-sample/amyotrophic-lateral-sclerosis-treatment-market.html

Amyotrophic Lateral Sclerosis Treatment Market Systems Market Segmentation:

  • By Disease Type
    • Sporadic ALS- Market Size & Forecast 2020-2030, USD Million
    • Familial ALS- Market Size & Forecast 2020-2030, USD Million
  • By Treatment
    • Medication- Market Size & Forecast 2020-2030, USD Million
      • Riluzole- Market Size & Forecast 2020-2030, USD Million
      • Edaravone- Market Size & Forecast 2020-2030, USD Million
      • Nuedexta- Market Size & Forecast 2020-2030, USD Million
      • Others
    • Stem Cell Therapy- Market Size & Forecast 2020-2030, USD Million
    • Others
  • By Distribution Channel
    • Hospital Pharmacies- Market Size & Forecast 2020-2030, USD Million
    • Retail Pharmacies- Market Size & Forecast 2020-2030, USD Million
    • Others
  • By Route of Administration
    • Oral- Market Size & Forecast 2020-2030, USD Million
    • Parenteral-Market Size & Forecast 2020-2030, USD Million
  • By End User
    • Hospitals- Market Size & Forecast 2020-2030, USD Million
    • Rehabilitation Centers- Market Size & Forecast 2020-2030, USD Million
    • Specialty Clinics-Market Size & Forecast 2020-2030, USD Million
    • Others- Market Size & Forecast 2020-2030, USD Million
  •  By Region
    • North America
    • South America
    • Europe
    • The Middle East & Africa
    • Asia-Pacific

 

Amyotrophic Lateral Sclerosis Treatment Market Recent Development:

  • February 2024: Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Group Corporation) launched Radicava for the treatment of ALS in Brazil at a local subsidiary of Daiichi Sankyo Company, Limited.
  • April 2023: Biogen received approval from the European Commission for QALSODY (tofersen) Therapy that treats SOD1-ALS. It is the third targeted drug that has been approved for the treatment of ALS.

 

Report Delivery Format – Market research reports from MarkNtel Advisors are delivered in PDF, Excel, and PowerPoint formats. Once the payment is successfully processed, the report will be sent to your registered email within 24 hours.

Amyotrophic Lateral Sclerosis Treatment Market Drivers:

Growing Prevalence of Amyotrophic Lateral Sclerosis – The rising cases of amyotrophic lateral sclerosis worldwide are one of the main factors that drive the market for this neurodegenerative condition. The disease is majorly growing in the North American region more likely to affect Whites and non-Hispanics. It is anticipated that the prevalence of amyotrophic lateral sclerosis will slightly increase as a result of the aging population, early diagnosis, and greater global awareness. Approximately 5,000 cases of amyotrophic lateral sclerosis are diagnosed every year in the US. Although it is a rare disease still the global prevalence rate of ALS is around 4–6 cases per 100,000 individuals. Furthermore, males have a higher prevalence than females comparatively but in old age, they are equally likely to be diagnosed with ALS. Sporadic ALS is making up to 90-95% of the total cases globally. Thus, the prevalence of ALS will continue to drive market growth during the forecast period.

Read Full Report: - https://www.marknteladvisors.com/research-library/amyotrophic-lateral-sclerosis-treatment-market.html

Report Highlights Essential Insights for Strategic Decision-Making

  • Detailed market size, share, and forecast analysis
    • In-depth pricing trends and segment-wise cost evaluations
    • Key industry strategies, including innovation, partnerships, and acquisitions
    • Critical value chain analysis and stakeholder profiling
    • Regional import-export market insights and trade flow assessment
    • Thorough competitive benchmarking of top hearing aid manufacturers
    • Identification of new growth opportunities and niche market segments
    • Overview of market trends, drivers, and challenges shaping future demand

Some of the leading players in the Amyotrophic Lateral Sclerosis Treatment Market are:

  • LafargeHolcim Saudi Arabia
  • UltraTech Cement Ltd.
  • GCC Cement Company
  • Emirates Cement Factory
  • Oman Cement Company
  • National Cement Company (Kuwait)
  • Al Khalij Cement
  • Qatar National Cement Company
  • RAK Cement
  • JSW Cement
  • Others

Research Methodology Summary

A systematic approach is used to ensure accurate market insights, combining both bottom-up and top-down methods. Data triangulation validates findings from multiple angles.

Key Steps:

  • Define objectives and research design
  • Collect data through surveys and interviews
  • Analyze and validate data using reliable tools
  • Forecast trends and deliver actionable insights

About us:

MarkNtel Advisors is a globally recognized market research and consulting firm delivering intelligence across the healthcare industry, spanning pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our analysts combine domain expertise with innovation tracking to help healthcare organizations improve efficiency and patient outcomes. Through Consulting Services, we assist clients in interpreting insights, designing go-to-market strategies, and adapting to regulatory changes, fostering sustainable growth in the evolving global healthcare ecosystem.

Trending blog:

Reach Us:

MarkNtel Advisors

Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com